Outlook Therapeutics, Inc. · NASDAQ:OTLK
Sukhtian Faisal Ghiath bought 122,174 Outlook Therapeutics, Inc. shares (Form 4)
Traded May 27, 2026 · Filed May 27, 2026
On May 27, 2026, Sukhtian Faisal Ghiath (Director) bought 122,174 Outlook Therapeutics, Inc. shares at US$0.41 for US$50,091, leaving 125,574 shares. Filed May 27, 2026 (Form 4).
- Bought
- 122,174 shares
- Price
- US$0.41
- Value
- US$50,091
- Holding after
- 125,574 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 27, 2026 | Common Stock | Buy | 122,174 | US$0.41 | 125,574 | Direct |
Source
Related
- Outlook Therapeutics, Inc.
- Sukhtian Faisal Ghiath
- Outlook Therapeutics, Inc. shareholders
- Form 4 · Sukhtian Faisal Ghiath · Jul 29, 2026
- Schedule 13G · Empery Asset Management, LP · Oct 13, 2026
- Schedule 13G · CVI Investments, Inc. · Aug 19, 2026
- Form 4 · Jahr Robert Charles · Aug 14, 2026
- Form 4 · Kenyon Lawrence A · Aug 14, 2026
- Form 4 · Sukhtian Ghiath M. · Aug 14, 2026